# Immuno-metabolic dysregulation in type 2 diabetes is associated with altered neutrophil functional plasticity, mitochondrial dysfunction, and compromised responses in sepsis

**Authors:** Kailash Ganesh, Sarah Michael Gomes, Sampara Vasishta, Ganesha Poojary, Pooja Yedehalli Thimmappa, Sruthi Peesapati, Shama Prasada Kabekkodu, Sandeep Mallya, Kanive Parashiva Guruprasad, Amit Singh, Shashikiran Umakanth, Sandipan Chakraborty, Manjunath B. Joshi

PMC · DOI: 10.1186/s12967-026-07696-z · Journal of Translational Medicine · 2026-01-10

## TL;DR

This study shows that type 2 diabetes disrupts neutrophil function and mitochondrial health, leading to worse sepsis outcomes, and suggests metabolic interventions may help.

## Contribution

The study reveals how immuno-metabolic dysregulation in T2D alters neutrophil function and mitochondrial health during sepsis.

## Key findings

- T2D alters neutrophil subpopulations, impairing their immune response during sepsis.
- T2D disrupts mitochondrial metabolism, reducing membrane potential and oxygen consumption.
- Arachidonic acid supplementation can restore NETs formation in T2D neutrophils during sepsis.

## Abstract

Constitutively activated neutrophil extracellular traps (NETs) have been implicated in the impeded response to infections in Type 2 Diabetes (T2D). However, immuno-metabolic factors contributing to functional plasticity of neutrophils in T2D associated infections are not known.

Using both human and mice model of sepsis with either diabetic or non-diabetic background, we investigated functionally confined neutrophil subpopulations either executing phagocytosis or NETosis. An integrated analysis of cytokines regulating granulopoiesis, RNAseq of NETs forming neutrophils and metabolomics was performed. Mitochondrial function was assessed via measuring mitochondrial membrane potential, cellular oxygen consumption rate and mitophagy.

We identified neutrophil subpopulations either executing phagocytosis or NETosis. Proportions of these functionally restricted neutrophils are significantly altered in T2D and fail to elicit an immune response upon induction of sepsis. Integrated analysis involving cytokines, transcriptome and metabolome data revealed perturbed immunometabolic axis in T2D models majorly effecting mitochondrial metabolism. Molecular dynamic simulations indicate deformed lipid densities and disrupted inner mitochondrial membrane. T2D neutrophils showed decrease in mitochondrial membrane potential, cellular oxygen consumption rate and mitophagy. Arachidonic acid supplementation activated mitochondrial ROS and restored NETs formation in T2D upon sepsis.

In mouse models, along with preliminary findings in human subjects, our study provides novel and correlative insights into the relationship between metabolic changes and neutrophil dysfunction in T2D-associated sepsis, exploring immuno-metabolism as a therapeutic target to improve neutrophil function.

The online version contains supplementary material available at 10.1186/s12967-026-07696-z.

## Linked entities

- **Chemicals:** arachidonic acid (PubChem CID 444899)
- **Diseases:** Type 2 Diabetes (MONDO:0005148)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** sepsis (MESH:D018805), mitochondrial dysfunction (MESH:D028361), type 2 diabetes (MESH:D003924)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12882159/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12882159/full.md

## References

13 references — full list in the complete paper: https://tomesphere.com/paper/PMC12882159/full.md

---
Source: https://tomesphere.com/paper/PMC12882159